CAR-T in Cancer Treatment: Develop in Self-Optimization, Win-Win in Cooperation

by Feifei Guo, Jiuwei Cui
Published 2021-04-01

Advances in Combination Therapy of Immune Checkpoint Inhibitors for Lung Cancer

by Hanfei GUO, Rilan BAI, Jiuwei CUI
Published 2020-02-01

Increased expression of claudin-17 promotes a malignant phenotype in hepatocyte via Tyk2/Stat3 signaling and is associated with poor prognosis in patients with hepatocellular carci...

by Lemeng Sun, Liangshu Feng, Jiuwei Cui
Published 2018-09-01

Gamma-delta (γδ) T cells: friend or foe in cancer development?

by Yijing Zhao, Chao Niu, Jiuwei Cui
Published 2018-01-01

Correction to: Gamma-delta (γδ) T cells: friend or foe in cancer development?

by Yijing Zhao, Chao Niu, Jiuwei Cui
Published 2018-05-01

Targeted Therapies for Driver Gene Mutation-positive Lung Cancer Patients with Brain Metastasis

by Wenqian LI, Rilan BAI, Jiuwei CUI
Published 2019-11-01

Study Progression on Non-small Cell Lung Cancer with EGFR Mutation 
Treated by Immune Checkpoint Inhibitors

by Rilan BAI, Naifei CHEN, Jiuwei CUI
Published 2018-08-01

The Lipid Metabolic Landscape of Cancers and New Therapeutic Perspectives

by Wenjun Wang, Ling Bai, Wei Li, Jiuwei Cui
Published 2020-12-01

Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors

by Rilan Bai, Zheng Lv, Dongsheng Xu, Jiuwei Cui
Published 2020-08-01

Efficacy and Safety of Epidermal Growth Factor Receptor (EGFR) Inhibitors Plus Antiangiogenic Agents as First-Line Treatments for Patients With Advanced EGFR-Mutated Non-small Cell...

by Fei Chen, Naifei Chen, Yu Yu, Jiuwei Cui
Published 2020-06-01

Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis

by Kaidireyahan Wumaier, Wenqian Li, Naifei Chen, Jiuwei Cui
Published 2021-09-01

Comprehensive Comparison Between Adjuvant Targeted Therapy and Chemotherapy for EGFR-Mutant NSCLC Patients: A Cost-Effectiveness Analysis

by Wenqian Li, Hanfei Guo, Lingyu Li, Jiuwei Cui
Published 2021-03-01

NK Cell Therapy: A Rising Star in Cancer Treatment

by Nawen Du, Feifei Guo, Yufeng Wang, Jiuwei Cui
Published 2021-08-01

Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy

by Zhongping Yin, Ling Bai, Wei Li, Tanlun Zeng, Huimin Tian, Jiuwei Cui
Published 2019-09-01

Neoadjuvant and Adjuvant Immunotherapy: Opening New Horizons for Patients With Early-Stage Non-small Cell Lung Cancer

by Rilan Bai, Lingyu Li, Xiao Chen, Naifei Chen, Wei Song, Jiuwei Cui
Published 2020-10-01

Sulforaphane Protects against Cardiovascular Disease via Nrf2 Activation

by Yang Bai, Xiaolu Wang, Song Zhao, Chunye Ma, Jiuwei Cui, Yang Zheng
Published 2015-01-01

Inhibition of HIV-1 Viral Infection by an Engineered CRISPR Csy4 RNA Endoribonuclease.

by Rui Guo, Hong Wang, Jiuwei Cui, Guanjun Wang, Wei Li, Ji-Fan Hu
Published 2015-01-01

Novel Frontiers of Treatment for Advanced Gastric or Gastroesophageal Junction Cancer (GC/GEJC): Will Immunotherapy Be a Future Direction?

by Rilan Bai, Naifei Chen, Tingting Liang, Lingyu Li, Zheng Lv, Xiaomin Lv, Jiuwei Cui
Published 2020-07-01

Hormetic Response to Low-Dose Radiation: Focus on the Immune System and Its Clinical Implications

by Jiuwei Cui, Guozi Yang, Zhenyu Pan, Yuguang Zhao, Xinyue Liang, Wei Li, Lu Cai
Published 2017-01-01

Nerves in the Tumor Microenvironment: Origin and Effects

by Wenjun Wang, Lingyu Li, Naifei Chen, Chao Niu, Zhi Li, Jifan Hu, Jifan Hu, Jiuwei Cui
Published 2020-12-01